Results 211 to 220 of about 60,441 (347)

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Differential Changes in Use of Medications for Opioid Use Disorder by Race-Ethnicity: Effects of a Hub-and-Spoke Model

Maureen T. Stewart, Shay M. Daily, Lee Panas, Sage R. Feltus, Margaret Lee, Grant A. Ritter, Sharon Reif   +6 more
openalex   +2 more sources

Medicaid prescription cap policies and exemptions for medications for opioid use disorder: A process and content analysis. [PDF]

Health Aff Sch
Hughto JMW, Vento S, Pletta DR, Noh M, Shireman TI, Santostefano CM, Hughes LD, Peterson L, Seymour E, Stettenbauer EG, Dow PM.   +10 more
europepmc   +1 more source

Risks and Risk Factors of Repeated Suicidal Attempt: Study of Unconscious Poisoned Patients [PDF]

Introduction: Most drug overdoses are due to suicidal attempts. This study was designed to analyze the risks and risk factors of poisoned patients with repeated suicidal attempt in Iran.
فرزانه, اسماعیل, مصطفی زاده, بابک   +1 more
core  

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +1 more source

"Convenience, Quickness, and Compassion": Experiences of People Involved in the Criminal-Legal System Accessing Medications for Opioid Use Disorder Services From a Mobile Unit in Chicago. [PDF]

Health Expect
Martinford T, Watson DP, Messmer S, Rashid L, Staton M, Dennis ML, Grella CE, Elmes-Patel A.   +7 more
europepmc   +1 more source

Opioids, Addiction Treatment, and the Long Tail of Eugenics [PDF]

, 2019
Appleman, Laura I.
core  

Characteristics of methamphetamine‐related deaths in the United Kingdom, 1997–2024

Addiction, EarlyView.
Abstract Background and aims People who use methamphetamine have a standardised mortality ratio 6.8 times greater than the general population, with several countries reporting concerning increases in methamphetamine‐related mortality over the past decade.
Emmert Roberts, Rebecca McKetin, Caroline Copeland   +2 more
wiley   +1 more source

Rurality weakens the positive association between the COVID-19 pandemic and substance use treatment involving medications for opioid use disorder. [PDF]

Drug Alcohol Depend Rep
Lofaro RJ, Confer LM, Bohler RM, Schwind JS.   +3 more
europepmc   +1 more source